BDBM50010194 16-(2-Acetylamino-6-amino-hexanoylamino)-7-carboxymethyl-3,3,13-trimethyl-6,9,12,15-tetraoxo-1,2-dithia-5,8,11,14-tetraaza-cycloheptadecane-4-carboxylic acid::CHEMBL2370405

SMILES C[C@@H]1NC(=O)[C@H](CSSC(C)(C)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)CNC1=O)C(O)=O)NC(=O)[C@H](CCCCN)NC(C)=O

InChI Key InChIKey=PGCYPBPWACRSTB-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50010194   

TargetIntegrin alpha-IIb/beta-3(Human)
Smithkline Beecham Pharmaceuticals Research and Development

Curated by ChEMBL
LigandPNGBDBM50010194(CHEMBL2370405 | 16-(2-Acetylamino-6-amino-hexanoyl...)
Affinity DataIC50: 2.00E+5nMAssay Description:Inhibition of canine platelet-rich plasma agregation induced by ADPMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed